Familial Nonmedullary Thyroid Cancer: A Review of the Genetics
Abstract
Objective: Thyroid cancer, the commonest of endocrine malignancies, continues to increase in incidence with over 19,000 new cases diagnosed in the European Union per year. Although nonmedullary thyroid cancer (NMTC) is mostly sporadic, evidence for a familial form, which is not associated with other Mendelian cancer syndromes (e.g., familial adenomatous polyposis and Cowden's syndrome), is well documented and thought to cause more aggressive disease. Just over a decade ago, the search for a genetic susceptibility locus for familial NMTC (FNMTC) began. This review details the genetic studies conducted thus far in the search for potential genes for FNMTC.
Design: An electronic PubMed search was performed from the English literature for genetics of FNMTC and genetics of familial papillary thyroid carcinoma (subdivision of FNMTC). The references from the selected papers were reviewed to identify further studies not found in the original search criteria.
Main Outcome: Six potential regions for harboring an FNMTC gene have been identified: MNG1 (14q32), TCO (19p13.2), fPTC/PRN (1q21), NMTC1 (2q21), FTEN (8p23.1–p22), and the telomere-telomerase complex. Important genes reported to have been excluded are RET, TRK, MET, APC, PTEN, and TSHR.
Conclusion: The genetics of FNMTC is an exciting field in medical research that has the potential to permit individualized management of thyroid cancer. Studies thus far have been on small family groups using varying criteria for the diagnosis of FNMTC. Results have been contradictory and further large-scale genetic studies utilizing emerging molecular screening tests are warranted to elucidate the underlying genetic basis of FNMTC.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Robinson DOrr T1955. Carcinoma of the thyroid and other diseases of the thyroid in identical twinsArch Surg70923-928. 1. Robinson D, Orr T 1955 Carcinoma of the thyroid and other diseases of the thyroid in identical twins. Arch Surg 70:923–928.
2.
Lote KAndersen KNordal EBrennhovd IO1980. Familial occurrence of papillary thyroid carcinomaCancer461291-1297. 2. Lote K, Andersen K, Nordal E, Brennhovd IO 1980 Familial occurrence of papillary thyroid carcinoma. Cancer 46:1291–1297.
3.
Ozaki OIto KKobayashi KSuzuki AManabe YHosoda Y1988. Familial occurrence of differentiated, nonmedullary thyroid carcinomaWorld J Surg12565-571. 3. Ozaki O, Ito K, Kobayashi K, Suzuki A, Manabe Y, Hosoda Y 1988 Familial occurrence of differentiated, nonmedullary thyroid carcinoma. World J Surg 12:565–571.
4.
Houlston RSStratton MR1995. Genetics of non-medullary thyroid cancerQ J Med88685-693. 4. Houlston RS, Stratton MR 1995 Genetics of non-medullary thyroid cancer. Q J Med 88:685–693.
5.
Burgess JRDuffield AWilkinson SJWare RGreenawa TMPercival JHoffman L1997. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroidJ Clin Endocrinol Metab82345-348. 5. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenawa TM, Percival J, Hoffman L 1997 Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82:345–348.
6.
Grossman RTu SDuh QSiperstein ANovosolov FClark O1995. Familial nonmedullary thyroid cancer an emerging entity that warrants aggressive treatmentArch Surg130892-899. 6. Grossman R, Tu S, Duh Q, Siperstein A, Novosolov F, Clark O 1995 Familial nonmedullary thyroid cancer an emerging entity that warrants aggressive treatment. Arch Surg 130:892–899.
7.
Schlumberger MJ1998. Papillary and follicular thyroid carcinomaN Engl J Med338297-306. 7. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306.
8.
Musholt TJMusholt PBPetrich TOetting GKnapp WHKlempnauer J2000. Familial papillary thyroid carcinoma: genetics criteria for diagnosis, clinical features and surgical treatmentWorld J Surg241409-1417. 8. Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J 2000 Familial papillary thyroid carcinoma: genetics criteria for diagnosis, clinical features and surgical treatment. World J Surg 24:1409–1417.
9.
Malchoff CMalchoff D1999. Familial nonmedullary thyroid carcinomaSemin Surg Oncol1616-18. 9. Malchoff C, Malchoff D 1999 Familial nonmedullary thyroid carcinoma. Semin Surg Oncol 16:16–18.
10.
Pal TBogl FDChappuis POTsang RBrierley JRenard HSanders KKantemiroff TBagha SGoldgar DENarod SAGoulkes WD2001. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based studyJ Clin Endocrinol Metab865307-5312. 10. Pal T, Bogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, Sanders K, Kantemiroff T, Bagha S, Goldgar DE, Narod SA, Goulkes WD 2001 Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86:5307–5312.
11.
Orsenigo EBeretta EGini PBerrecchia FInvernizzi LFiorina PCarlo VD2003. A report of six cases of familial papillary thyroid cancerEur J Surg Oncol29185-187. 11. Orsenigo E, Beretta E, Gini P, Berrecchia F, Invernizzi L, Fiorina P, Carlo VD 2003 A report of six cases of familial papillary thyroid cancer. Eur J Surg Oncol 29:185–187.
12.
Frich LGlattre EAkslen LA2001. Familial occurrence of nonmedullary thyroid cancer: a population based study of 5673 first degree relatives of thyroid cancer patients from NorwayCancer Epidemiol Biomarkers Prev10113-117. 12. Frich L, Glattre E, Akslen LA 2001 Familial occurrence of nonmedullary thyroid cancer: a population based study of 5673 first degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev 10:113–117.
13.
Maxwell ELHall FTFreeman JL2004. Familial non-medullary thyroid cancer: a matched-case control studyLaryngoscope1142182-2186. 13. Maxwell EL, Hall FT, Freeman JL 2004 Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope 114:2182–2186.
14.
Malchoff CMalchoff D2006. Familial nonmedullary thyroid carcinomaCancer Control13106-110. 14. Malchoff C, Malchoff D 2006 Familial nonmedullary thyroid carcinoma. Cancer Control 13:106–110.
15.
Takami HOzai OIto K1996. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatmentArch Surg131676. 15. Takami H, Ozai O, Ito K 1996 Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Arch Surg 131:676.
16.
Alsanea OWada NAin KWong MTaylor KItuarte PHGTreseler PAWier HUFreimer NSiperstein AEDuh QYTakami HClark OH2000. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter seriesSurgery1281043-1051. 16. Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PHG, Treseler PA, Wier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH 2000 Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043–1051.
17.
Capezzone MMarchisotta SCantara SBusonero GBrilli LPanayiotou KPCarli AFCaruso GToti PCapitani SPammolli APacini F2008. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entityEndocr Relat Cancer151075-1081. 17. Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Panayiotou KP, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F 2008 Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075–1081.
18.
Sipper RSCaron NRClark OH2007. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management and follow upWorld J Surg31924-933. 18. Sipper RS, Caron NR, Clark OH 2007 An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management and follow up. World J Surg 31:924–933.
19.
Kebew E2008. Hereditary non-medullary thyroid cancerWorld J Surg32678-682. 19. Kebew E 2008 Hereditary non-medullary thyroid cancer. World J Surg 32:678–682.
20.
Sturgeon CClark OH2005. Familial nonmedullary thyroid cancerThyroid15588-593. 20. Sturgeon C, Clark OH 2005 Familial nonmedullary thyroid cancer. Thyroid 15:588–593.
21.
Huang JVieland VJ2001. The null distribution of heterogeneity LOD score does depend on the assumed genetic model for the traitHum Hered52217-222. 21. Huang J, Vieland VJ 2001 The null distribution of heterogeneity LOD score does depend on the assumed genetic model for the trait. Hum Hered 52:217–222.
22.
Bignell GCanzian FShayeghi MStark MShugart YBiggs PMangion JHamoudi RRosenblatt JBuu PSun SStoffer SGoldgar DRomeo GHoulston RNarod SStratton MFoulkes W1997. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancerAm J Hum Genet611123-1130. 22. Bignell G, Canzian F, Shayeghi M, Stark M, Shugart Y, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer S, Goldgar D, Romeo G, Houlston R, Narod S, Stratton M, Foulkes W 1997 Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123–1130.
23.
Lesueur FStark MTocco TAyadi HDelisle JGoldgar DESchlumberger MRomeo GCanzian F1999. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 familiesJ Clin Endocrinol Metab842157-2162. 23. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle J, Goldgar DE, Schlumberger M, Romeo G, Canzian F 1999 Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. J Clin Endocrinol Metab 84:2157–2162.
24.
McKay JDWilliamson JLesueur FStark MDuffield ACanzian FRomeo GHoffman L1999. At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian familyEur J Endocrinol141122-125. 24. McKay JD, Williamson J, Lesueur F, Stark M, Duffield A, Canzian F, Romeo G, Hoffman L 1999 At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family. Eur J Endocrinol 141:122–125.
25.
Malchoff CSarfarazi MTendler BForouhar FWhalen GJoshi VArnold AMalchoff D2000. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumour syndromeJ Clin Endocrinol Metab851758-1764. 25. Malchoff C, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff D 2000 Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumour syndrome. J Clin Endocrinol Metab 85:1758–1764.
26.
Cavaco BMBatista PFMartins CBanito ARosario FDLimbert ESobrinho LGLeite V2008. Familial non-medullary thyroid carcinoma (FNMTC): analysis of Fptc/PRN, NMTC1, MNG1 and TCO susceptibility loci identification of somatic BRAF and RAS mutationsEndocr Relat Cancer15207-215. 26. Cavaco BM, Batista PF, Martins C, Banito A, Rosario FD, Limbert E, Sobrinho LG, Leite V 2008 Familial non-medullary thyroid carcinoma (FNMTC): analysis of Fptc/PRN, NMTC1, MNG1 and TCO susceptibility loci identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15:207–215.
27.
Canzian FAmati PHarach HKraimps JLLesueur FBarbier JLevillain PRomeo GBonneau D1998. A gene predisposing to familial thyroid tumours with cell oxyphiia maps to chromosome 19p13.2Am J Hum Genet631743-1748. 27. Canzian F, Amati P, Harach H, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998 A gene predisposing to familial thyroid tumours with cell oxyphiia maps to chromosome 19p13.2. Am J Hum Genet 63:1743–1748.
28.
Bevan SPal TGreenberg CRGreen HWixey JBignell GNarod SAFoulkes WDStratton MRHoulston RS2001. A comprehensive analysis of NG1, TCO1, fPTc, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1J Clin Endocrinol Metab863701-3704. 28. Bevan S, Pal T, Greenberg CR, Green H, Wixey J, Bignell G, Narod SA, Foulkes WD, Stratton MR, Houlston RS 2001 A comprehensive analysis of NG1, TCO1, fPTc, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 86:3701–3704.
29.
McKay JDThompson DLesueur FStankov KPastore AWatfah CStrolz SRiccabona GMoncayo RRomeo GGoldgar DE2004. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancerJ Med Genet41407-412. 29. McKay JD, Thompson D, Lesueur F, Stankov K, Pastore A, Watfah C, Strolz S, Riccabona G, Moncayo R, Romeo G, Goldgar DE 2004 Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet 41:407–412.
30.
Stankov KPastore ATosch LMcKay JLesuer FKraimps JLBonneau DGibelin HLevillain PBolante MPapotti MRomeo G2004. Allelic loss on chromosomes 2q21 and 19p13.2 in oxyphilic thyroid tumoursInt J Cancer111463-467. 30. Stankov K, Pastore A, Tosch L, McKay J, Lesuer F, Kraimps JL, Bonneau D, Gibelin H, Levillain P, Bolante M, Papotti M, Romeo G 2004 Allelic loss on chromosomes 2q21 and 19p13.2 in oxyphilic thyroid tumours. Int J Cancer 111:463–467.
31.
Prazeres HGRodrigues FSoares PNaidenov PFigueiredo PCampos BLacerda MMartins T2008. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid cancerFam Cancer7141-149. 31. Prazeres HG, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B, Lacerda M, Martins T 2008 Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid cancer. Fam Cancer 7:141–149.
32.
McKay JDLesueur FJonard LPastore AWilliamson JHoffman LBurgess JDuffield APapotti MStark MSobol HMaes BMurat AKaariainen HBertholon-Gregoire MZini MRossing MAToubert MEBonichon FCavarec MBernard AMBoneu ALeprat FHaas OLasset CSchlumberger MCanzian FGoldgar DERomeo G2001. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q2169440-446. 32. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, Murat A, Kaariainen H, Bertholon-Gregoire M, Zini M, Rossing MA, Toubert ME, Bonichon F, Cavarec M, Bernard AM, Boneu A, Leprat F, Haas O, Lasset C, Schlumberger M, Canzian F, Goldgar DE, Romeo G 2001 Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. 69:440–446.
33.
Capezzone MCantara SMarchisotta SFiletti SDe Santi MMRossi BRonga GCurante CPacini F2008. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patientsJ Clin Endocrinol Metab933950-3957. 33. Capezzone M, Cantara S, Marchisotta S, Filetti S, De Santi MM, Rossi B, Ronga G, Curante C, Pacini F 2008 Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin Endocrinol Metab 93:3950–3957.
34.
Cavaco BMBatista PFSobrinho LGLeite V2008. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high density single nucleotide polymorphism genome-wide linkage analysisJ Clin Endocrinol Metab934426-4430. 34. Cavaco BM, Batista PF, Sobrinho LG, Leite V 2008 Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high density single nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 93:4426–4430.
35.
Lonn SBhatti PAlexander BHPineda MADoody MMStruewing JPSigurdson AJ2007. Papillary thyroid cancer and polymorphic variants in TSHR-and RET-related genes: a nested case-control study with a cohort of U.S. radiologic technologistsCancer Epidemiol Biomarkers Prev16174-177. 35. Lonn S, Bhatti P, Alexander BH, Pineda MA, Doody MM, Struewing JP, Sigurdson AJ 2007 Papillary thyroid cancer and polymorphic variants in TSHR-and RET-related genes: a nested case-control study with a cohort of U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev 16:174–177.
36.
Corvi RLesueur FMartinez-alfaro MZini MDecaussin MMurat ARomeo G2001. RET rearrangements in familial papillary thyroid carcinomasCancer Lett170191-198. 36. Corvi R, Lesueur F, Martinez-alfaro M, Zini M, Decaussin M, Murat A, Romeo G 2001 RET rearrangements in familial papillary thyroid carcinomas. Cancer Lett 170:191–198.
37.
Kraimps JLCanzian FJost CMenet EAmati PLevillian PHarach RLesueur FBarbier JRomeo GBonneau D1999. Mapping of a gene predisposing to familial thyroid tumours with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate geneSurgery1261184-1194. 37. Kraimps JL, Canzian F, Jost C, Menet E, Amati P, Levillian P, Harach R, Lesueur F, Barbier J, Romeo G, Bonneau D 1999 Mapping of a gene predisposing to familial thyroid tumours with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene. Surgery 126:1184–1194.
38.
Xing M2005. The T1799a BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancerClin Endocrinol63263-266. 38. Xing M 2005 The T1799a BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol 63:263–266.
39.
Charkes ND2006. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindredsThyroid16181-186. 39. Charkes ND 2006 On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181–186.
Information & Authors
Information
Published In
Copyright
Copyright 2010, Mary Ann Liebert, Inc.
History
Published online: 6 July 2010
Published in print: July 2010
Published ahead of print: 14 May 2010
Topics
Authors
Disclosure Statement
The authors declare that no competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.